{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:37:55Z","timestamp":1786736275086,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol India"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/0028-3886.271236","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T02:22:46Z","timestamp":1574302966000},"page":"1286","source":"Crossref","is-referenced-by-count":5,"title":["Ozagrel for Postoperative Management of Aneurysmal Subarachnoid Hemorrhages"],"prefix":"10.4103","volume":"67","author":[{"given":"DhananjayaI","family":"Bhat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinayak","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhaval","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AR","family":"Prabhuraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BhagavatulaI","family":"Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0028-3886.271236-1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1586\/14737175.2015.1018892","article-title":"Aneurysmal subarachnoid hemorrhage: Pathobiology, current treatment and future directions","author":"Serrone","year":"2015","journal-title":"Expert Rev Neurother"},{"key":"key-10.4103\/0028-3886.271236-2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2176\/nmc.48.241","article-title":"Safety and efficacy of fasudil monotherapy and fasudil-ozagrel combination therapy in patients with subarachnoid hemorrhage: Sub-analysis of the post-marketing surveillance study","author":"Suzuki","year":"2008","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"key-10.4103\/0028-3886.271236-3","first-page":"762","article-title":"Effect of selective thromboxane synthetase inhibitor 0KY-046 on delayed cerebral vasospasm following the ruptured cerebral aneurysm","author":"Kawano","year":"1986","journal-title":"Shinyaku To Rinsho"},{"key":"key-10.4103\/0028-3886.271236-4","first-page":"554","article-title":"Sodium Ozagrel","author":"Kitakawa","year":"2006","journal-title":"Nihon Rinsho"},{"key":"key-10.4103\/0028-3886.271236-5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/01616412.1989.11739867","article-title":"Clinical study of OKY-046, a thromboxane synthetase inhibitor, in prevention of cerebral vasospasms and delayed cerebral ischaemic symptoms after subarachnoid haemorrhage due to aneurysmal rupture: A randomized double-blind study","author":"Suzuki","year":"1989","journal-title":"Neurol Res"},{"key":"key-10.4103\/0028-3886.271236-6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2169\/internalmedicine.44.365","article-title":"Therapeutic strategy for acute stroke--prologue for an epoch of brain attack-The present state of acute ischemic stroke therapy in Japan","author":"Okada","year":"2005","journal-title":"Intern Med"},{"key":"key-10.4103\/0028-3886.271236-7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1747-4949.2008.00178.x","article-title":"Outline of the Japanese Guidelines for the Management of Stroke 2004 and subsequent revision","author":"Shinohara","year":"2008","journal-title":"Int J Stroke"},{"key":"key-10.4103\/0028-3886.271236-8","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","article-title":"Definition of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage as an Outcome Event in Clinical Trials and Observational Studies: Proposal of a Multidisciplinary Research Group","author":"Vergouwen","year":"2010","journal-title":"Stroke"},{"key":"key-10.4103\/0028-3886.271236-9","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0140-6736(75)92830-5","article-title":"Assessment of outcome after severe brain damage","author":"Jennet","year":"1975","journal-title":"Lancet"},{"key":"key-10.4103\/0028-3886.271236-10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0090-3019(91)90228-2","article-title":"Efficacy and toxicity of thromboxane synthetase inhibitor for cerebral vasospasm after subarachnoid hemorrhage","author":"Tokiyoshi","year":"1991","journal-title":"Surg Neurol"},{"key":"key-10.4103\/0028-3886.271236-11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2176\/nmc.38.805","article-title":"Combination Therapy of Fasudil Hydrochloride and Ozagrel Sodium for Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage","author":"Nakashima","year":"1998","journal-title":"Neurol Med Chir (Tokyo)"}],"container-title":["Neurology India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:39:46Z","timestamp":1786732786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.271236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"alternative-id":["271236"],"URL":"https:\/\/doi.org\/10.4103\/0028-3886.271236","relation":{},"ISSN":["0028-3886"],"issn-type":[{"value":"0028-3886","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}